期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

流感大流行及其应对策略 被引量：10

下载PDF
导出
摘要 内容:介绍流感病毒的特点、危害、流行情况、流感的预防与治疗、世界卫生组织制定的“国家流感大流行计划指南”以及流感信息相关国际机构的网址。目的:引起人们对未来流感大爆发的普遍关注,便于流感相关信息的查询,为我国预防医学工作者应对可能爆发的流感疫情提供参考。
作者 裴晓方 姚玉红 许欣
机构地区 四川大学华西公共卫生学院
出处 《现代预防医学》 CAS 北大核心 2005年第5期568-570,共3页 Modern Preventive Medicine
关键词 大流行 应对策略 世界卫生组织 预防与治疗 医学工作者 流感病毒 流行情况 国际机构 流感疫情 相关 信息 爆发
分类号 R184.35 [医药卫生—流行病学] R563.1 [医药卫生—呼吸系统]
  • 相关文献

参考文献12

  • 1戚凤春,盛军.流感疫苗的研究进展[J].中国生物制品学杂志,2004,17(3):190-192. 被引量：26
  • 2WHO, Geneva. Estimating the impact of the next influenza pandemic:enhancing preparedness [ EB/DL ] . 2004; http: //www.who.int/csr/disease/influenza/preparedness. 2004-12-08.
  • 3Hilleman, Maurice R. Realities and enigmas of human viral influenza:pathogenesis, epidemiology and control [J] .Vaccine 2002; 20 (25-26): 3068-3087.
  • 4Wright PF, Webster RG. Orthomyxoviruses [M] .In: Knipe DM,Howley PM, editors. Fields virology, vol. 1.4th ed. Philadelphia: Lippincott Williams and Wilkins, 2001. p. 1533 -79.
  • 5Snacken R, Kendal AP, Haaheim LR, Wood JM. The next influenza pandemic: lessons from Hong Kong [J] .1997. Emerg Infect Dis1999; 5: 195-203.
  • 6Cox NJ, Subbarao K. Ifluenza [J] .Lancet 1999; 354: 1277-82.
  • 7WHO. Pandemic preparedness [EB/DL] http: //www. who.int/csr/disease/influenza/pandemic/en/.
  • 8WHO. Influenza [ EB/DL] . Fifty - sixth world health assembly 2003;http: //www. who. int/influenza.
  • 9WHO. Influenza Pandemic Plan [ EB/DL] . The Role of WHO and Guidelines for National and Regional Planning. 1999.
  • 10WHO. WHO Guidelines on the Use of Vaccines and Antivirals during Influenza Pandemics [ EB/DL] .WHO/CDS/CSR/RMD/2004.8..

二级参考文献11

  • 1Chen Z, Matsuok, Asanumah, et al. Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin-and neuraminidase-expressing DNAs. Vaccine, 1999,17(7-8) :653-659.
  • 2Levi R, Aboud-Pirok E A, Leclerc C, et al. Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes. Vaccine, 1995,13:1353-1359.
  • 3John J T, Robert F B,Gale E S,et al. Evaluation of a recombinant Hemagglutinin expressed in insect cells as an influenza yaccinc in young and elderly adults. J Infect Dis, 1996,174:1467-1470.
  • 4Parkin N T, Chiu P, Coelingh K. Genetically engineered live attenuated influenza A virus vaccine candidates. J Virol, 1997,71: 2772-2778.
  • 5Hilbert A K, McCarthy L, Mills K H. Biodegradable microspheres containing influenza a vaccine Immune response in mice. Vaccine, 1999,17:1065-1073.
  • 6Robert B B. A review of attenuation of influenza virus by genetic manipulation. Am J Respir Crit Med, 1995,152:72-75.
  • 7Arnon R , Levi R. Synthetic reconbinant vaccines against viral agents. Int Arch Allergy Immunol, 1995,108: 321-326.
  • 8Harley V R, Mather K A,Power B E,et al. Characterization of an avian influenza virus nucleoprotein expressed in E. coli and in insect cells. Arch Virol, 1990,113: 267-277.
  • 9Mather H A, White J F, Hudson P J, et al. Expression of influenza neureminidase in baculovirus-infected cells. Virus Res, 1992,26:12715.
  • 10Lakey D L, Treanor J, Betts R F, et al. Recombinant Baculivirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults. J Infect Dis, 1996,174:838-841.

共引文献25

同被引文献103

引证文献10

二级引证文献108

现代预防医学
2005年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部